Biocon informs about company statement

23 Jul 2025 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Biologics Launches Nepexto®, a Biosimilar to Enbrel® (Etanercept), in Australia’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE. 

Biocon Share Price

377.80 2.55 (0.68%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×